This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Dec;12(12):444-6.

doi: 10.1016/0165-6147(91)90630-b.

Mode of action of the anti-migraine drug sumatriptan

P P Humphrey¹, W Feniuk

Affiliations

PMID: 1665260
DOI: 10.1016/0165-6147(91)90630-b

Review

Mode of action of the anti-migraine drug sumatriptan

P P Humphrey et al. Trends Pharmacol Sci. 1991 Dec.

. 1991 Dec;12(12):444-6.

doi: 10.1016/0165-6147(91)90630-b.

Authors

P P Humphrey¹, W Feniuk

Affiliation

¹ Pharmacology Division, Glaxo Group Research Limited, Ware, Herts, UK.

PMID: 1665260
DOI: 10.1016/0165-6147(91)90630-b

No abstract available

PubMed Disclaimer

Similar articles

Anti-migraine drugs in development: advances in serotonin receptor pharmacology.
Humphrey PP, Feniuk W, Perren MJ. Humphrey PP, et al. Headache. 1990 Jan;30(1 Suppl):12-6; discussion 24-8. doi: 10.1111/j.1526-4610.1990.hed30s1012.x. Headache. 1990. PMID: 2157682 No abstract available.
Sumatriptan for the treatment of acute migraine headache.
Long K, Long R. Long K, et al. Nurse Pract Forum. 1993 Sep;4(3):124-5. Nurse Pract Forum. 1993. PMID: 8396482 No abstract available.
Sumatriptan.
Walters DJ. Walters DJ. Axone. 1992 Jun;13(4):132. Axone. 1992. PMID: 1318067 No abstract available.
Sumatriptan in acute migraine: pharmacology and review of world experience.
Peroutka SJ. Peroutka SJ. Headache. 1990;30 Suppl 2:554-60. doi: 10.1111/j.1526-4610.1990.hed30s2554.x. Headache. 1990. PMID: 2177047 Review.
SUMATRIPTAN: a receptor-targeted treatment for migraine.
Moskowitz MA, Cutrer FM. Moskowitz MA, et al. Annu Rev Med. 1993;44:145-54. doi: 10.1146/annurev.me.44.020193.001045. Annu Rev Med. 1993. PMID: 8386498 Review.

See all similar articles

Cited by

Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries.
Terrón JA, Falcón-Neri A. Terrón JA, et al. Br J Pharmacol. 1999 Jun;127(3):609-16. doi: 10.1038/sj.bjp.0702580. Br J Pharmacol. 1999. PMID: 10401550 Free PMC article.
Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
Tfelt-Hansen P, De Vries P, Saxena PR. Tfelt-Hansen P, et al. Drugs. 2000 Dec;60(6):1259-87. doi: 10.2165/00003495-200060060-00003. Drugs. 2000. PMID: 11152011 Review.
The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Williamson DJ, Hill RG, Shepheard SL, Hargreaves RJ. Williamson DJ, et al. Br J Pharmacol. 2001 Aug;133(7):1029-34. doi: 10.1038/sj.bjp.0704162. Br J Pharmacol. 2001. PMID: 11487512 Free PMC article.
No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
Bouchelet I, Case B, Olivier A, Hamel E. Bouchelet I, et al. Br J Pharmacol. 2000 Feb;129(3):501-8. doi: 10.1038/sj.bjp.0703081. Br J Pharmacol. 2000. PMID: 10711348 Free PMC article.
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.
Jhee SS, Shiovitz T, Crawford AW, Cutler NR. Jhee SS, et al. Clin Pharmacokinet. 2001;40(3):189-205. doi: 10.2165/00003088-200140030-00004. Clin Pharmacokinet. 2001. PMID: 11327198 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information